Gizmodo
A Game-Changing Drug for Pancreatic Cancer Just Got FDA Approval
In a large-scale clinical trial, people taking daraxonrasib lived twice as long as those given standard chemotherapy.
Shown as published in the source's RSS feed. IndiaAIFounders doesn't link out to third-party sites — this is the complete detail available from the feed itself.